Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Cytyc Expands Women’s Health Niche With Novacept Menorrhagia Treatment

Related Content

Novacept NovaSure To Compete With Ethicon In U.S. Menorrhagia Market

Oct 15 2001

Cytyc Has About $180 Mil. To Invest Following Collapse Of Digene Merger

Jul 08 2002

More from Archive

More from Medtech Insight

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window